Table 1 Cohort description for cancer type and therapy
Age at Diagnosis | |||||
|---|---|---|---|---|---|
n | % | mean (years) | STDEV | Median | |
All | 1031 | 55.4 | 11.4 | 54.7 | |
HR+/HER2+ | 195 | 18.9 | 55.8 | 11.2 | 55.6 |
HR+/HER2- | 563 | 54.6 | 56.0 | 11.4 | 55.1 |
HR+/HER2? | 4 | 0.4 | 50.1 | 8.4 | 52.5 |
HR-/HER2+ | 51 | 4.9 | 52.1 | 11.0 | 50.5 |
HR-/HER2? | 1 | 0.1 | 53.2 | . | 53.2 |
HR/HER2? | 109 | 10.6 | 55.4 | 11.5 | 53.9 |
Triple- | 108 | 10.5 | 53.5 | 11.7 | 53.0 |
Therapy combinations | |||||
MT/CHT/Surg/RT | 624 | 60.5 | 55.0 | 10.81 | 54.5 |
MT/CHT/Surg | 183 | 17.7 | 55.1 | 12.15 | 53.1 |
MT/CHT/RT | 21 | 2.0 | 54.4 | 10.10 | 53.9 |
MT/CHT | 28 | 2.7 | 58.0 | 14.24 | 59.3 |
MT/Surg/RT | 43 | 4.2 | 58.4 | 11.96 | 58.7 |
MT/Surg | 71 | 6.9 | 57.7 | 13.08 | 55.9 |
MT/RT | 1 | 0.1 | 80.0 | . | 80.0 |
MT | 60 | 5.8 | 55.1 | 11.26 | 53.3 |